Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$286,450,985
+$40,864,806 QoQ
Shares Held
1,127,893
+12.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#161
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. JNJ ranks #6 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,450,985 | 1,127,893 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $245,586,179 | 1,004,689 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $519,222,235 | 2,508,926 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $429,149,027 | 2,314,470 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $375,636,384 | 2,459,158 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $547,496,879 | 3,301,356 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $342,266,369 | 2,366,660 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $186,831,843 | 1,152,856 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,037,434 | 828,116 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $111,786,545 | 706,660 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $6,471,879 | 41,553 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $188,257,265 | 1,214,563 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $140,561,111 | 795,704 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,152,456 | 92,755 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,299,383 | 29,854 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,179,219,300 | 6,653,610 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $829,343,596 | 4,847,978 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $856,659,308 | 5,304,392 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,141,445,075 | 6,928,767 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,479,970,763 | 9,004,994 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $994,017,903 | 6,316,037 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,151,478,713 | 7,734,274 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,109,117,871 | 7,886,780 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $926,752,095 | 7,067,430 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||